The recent International Symposium on Molecular-epidemiology in Embryonal tumours and paediatric leukaemia was held on March 4-6 2008 in Rio de Janeiro, Brazil. It was a very productive meeting in which studies relating to genetics and therapeutical trials, identification of risk factors in acute leukaemia neuroblastoma and WilmsÂ’ tumours were presented. Over one hundred and twenty participants gathered for three days of fruitful discussions, including representatives of paediatrics, haematology, laboratory, epidemiology and pathology. Debates about strategies of applications of important biomarkers for clinical trials were discussed. Highlights of each of the scientific presentations are summarised below.
Further information:
Related posts:
- Report of the Integrative Molecular Cancer Epidemiology International Symposium, Lyon, France
- Institutional guidelines and ongoing studies in management of liver tumours: The experience of the European Institute of Oncology
- NICE Set To Recommend Rituximab For Relapsed Or Refractory Chronic Lymphocytic Leukaemia
- 2007 EORTC-NCI-ASCO Annual Meeting: Molecular Markers in Cancer
- Somatostatin analogues in the treatment of gastroenteropancreatic neuroendocrine tumours, current aspects and new perspectives
Posted in